PMID- 15131121 OWN - NLM STAT- MEDLINE DCOM- 20040817 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 279 IP - 29 DP - 2004 Jul 16 TI - Casein kinase 1alpha interacts with retinoid X receptor and interferes with agonist-induced apoptosis. PG - 30844-9 AB - Agonists of retinoid X receptors (RXRs), which include the natural 9-cis-retinoic acid and synthetic analogs, are potent inducers of growth arrest and apoptosis in some cancer cells. As such, they are being used in clinical trials for the treatment and prevention of solid tumors and are used to treat cutaneous T cell lymphoma. However, the molecular mechanisms that underlie the anti-cancer effects of RXR agonists remain unclear. Here, we show that a novel pro-apoptotic pathway that is induced by RXR agonist is negatively regulated by casein kinase 1alpha (CK1alpha). CK1alpha associates with RXR in an agonist-dependent manner and phosphorylates RXR. The ability of an RXR agonist to recruit CK1alpha to a complex with RXR in cells correlates inversely with its ability to inhibit growth. Remarkably, depletion of CK1alpha in resistant cells renders them susceptible to RXR agonist-induced growth inhibition and apoptosis. Our study shows that CK1alpha can promote cell survival by interfering with RXR agonist-induced apoptosis. Inhibition of CK1alpha may enhance the anti-cancer effects of RXR agonists. FAU - Zhao, Yi AU - Zhao Y AD - Retinoid Research, Department of Biology, Allergan Inc., Irvine, California 92612, USA. zhao_yi@allergan.com FAU - Qin, Suofu AU - Qin S FAU - Atangan, Larissa I AU - Atangan LI FAU - Molina, Yanira AU - Molina Y FAU - Okawa, Yumiko AU - Okawa Y FAU - Arpawong, Hieu T AU - Arpawong HT FAU - Ghosn, Corine AU - Ghosn C FAU - Xiao, Jia-Hao AU - Xiao JH FAU - Vuligonda, Vidyasagar AU - Vuligonda V FAU - Brown, Geoffrey AU - Brown G FAU - Chandraratna, Roshantha A S AU - Chandraratna RA LA - eng PT - Journal Article DEP - 20040506 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Ligands) RN - 0 (RNA, Small Interfering) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Retinoid X Receptors) RN - 0 (Transcription Factors) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.11.1 (Casein Kinases) SB - IM MH - Animals MH - *Apoptosis MH - Casein Kinases MH - Cell Line MH - Cell Survival MH - Dimerization MH - Dose-Response Relationship, Drug MH - Flow Cytometry MH - Genetic Vectors MH - HeLa Cells MH - Humans MH - Immunoblotting MH - Jurkat Cells MH - Ligands MH - Lymphoma, T-Cell/metabolism MH - Phosphorylation MH - Precipitin Tests MH - Protein Binding MH - Protein Kinases/chemistry/*metabolism MH - RNA, Small Interfering/metabolism MH - Rats MH - Receptors, Retinoic Acid/chemistry/*metabolism MH - Retinoid X Receptors MH - Transcription Factors/chemistry/*metabolism MH - Transcriptional Activation MH - Transfection EDAT- 2004/05/08 05:00 MHDA- 2004/08/18 05:00 CRDT- 2004/05/08 05:00 PHST- 2004/05/08 05:00 [pubmed] PHST- 2004/08/18 05:00 [medline] PHST- 2004/05/08 05:00 [entrez] AID - S0021-9258(19)71108-9 [pii] AID - 10.1074/jbc.M404651200 [doi] PST - ppublish SO - J Biol Chem. 2004 Jul 16;279(29):30844-9. doi: 10.1074/jbc.M404651200. Epub 2004 May 6.